The global levofloxacin market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Levofloxacin is an antibiotic medication. It is sold under the brand name Levaquin, among others and is used for the treatment of several bacterial infections including acute bacterial sinusitis, pneumonia, H. pylori, urinary tract infections, chronic prostatitis, and some types of gastroenteritis. The major factor driving the growth of the market is the increasing prevalence of pneumonia across the globe.
According to the World Health Organization (WHO), in 2019, pneumonia accounted for 14% of all children’s mortality with a mortality rate of 740,180 children under the age of five. Additionally, as per UNICEF 2021, the mortality rate due to pneumonia is more than 800,000 children under five every year or around 2,200 every day which includes over 153,000 newborns. Further, there are more than 1,400 cases of pneumonia per 100,000 children or 1 case per 71 children every year globally. Hence, the rising prevalence of pneumonia leads to an increasing risk for bacterial infections which in turn is creating demand for the global levofloxacin market during the forecast period.
To Request a Sample of our Report on Levofloxacin Market: https://www.omrglobal.com/request-sample/levofloxacin-market
Some major players in the market include Cadila Healthcare Ltd., Dr. Reddy’s Laboratories, and Lupin Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in July 2020, Novartis announced the launch of a new initiative to support patients in low-income and lower-middle-income countries. This initiative allows access to affordable medicines to treat the major symptoms of COVID-19. The drug portfolio includes Levofloxacin, Loperamide, Pantoprazole, Prednisone, Prednisolone, among others.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Product Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- Cadila Healthcare Ltd., Dr. Reddy’s Laboratories, and Lupin Ltd., among others.
(Get 15% Discount on Buying this Report)
A full Report of Levofloxacin Market is Available @ https://www.omrglobal.com/industry-reports/levofloxacin-market
Global Levofloxacin Market Report by Segment
By Product Type
- 250 MG
- 500 MG
- 750 MG
By Application
- Pneumonia
- Skin Infection
- Kidney Infection
- Bladder Infection
- Other
Global Levofloxacin Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
